2012 Annual Meeting | Therapy of Stroke

Date Friday 04/27/12

Time 09:00 AM - 11:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Therapy Program

Director(s) Bruce I. Ovbiagele, MD, MSc, F�鶹��ýӳ��

Topic(s)

Learning Objectives Participants should be knowledgeable about the optimal management of acute cerebral infarction, including general medical strategies, thrombolytic treatment, endovascular therapy, and surgical approaches, as well as their relevant therapeutic windows; and develop a logical framework for promptly implementing various vascular risk reduction strategies after acute or recent cerebral ischemia including selection of antithrombotic agents, lipid modifiers, antihypertensive therapies, and revascularization procedures.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Case-based, Didactic, Audience Participation

Program Evaluations

Event Timeline
09:00 AM - 09:45 AM		Evidence-Based, Cutting-Edge and Practical Aspects of Acute Ischemic Stroke Management Pooja Khatri, MD, F�鶹��ýӳ��
09:00 AM - 11:00 AM		Break
09:45 AM - 10:30 AM		Secondary Stroke Prevention in 2012: New Targets and New Arrows Scott E. Kasner, MD, F�鶹��ýӳ��
10:30 AM - 11:00 AM		Questions and Answers Scott E. Kasner, MD, F�鶹��ýӳ��, Pooja Khatri, MD, F�鶹��ýӳ��

Faculty Disclosures
Bruce I. Ovbiagele, MD, MSc, F�鶹��ýӳ��	Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to �鶹��ýӳ�� interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to �鶹��ýӳ�� interests or activities.
Pooja Khatri, MD, F�鶹��ýӳ��	Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Silvercreek. The institution of Dr. Khatri has received research support from NIH/NINDS. The institution of Dr. Khatri has received research support from AHA. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Scott E. Kasner, MD, F�鶹��ýӳ��	Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Javelin. Dr. Kasner has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Kasner has received research support from WL Gore. The institution of Dr. Kasner has received research support from DiaMedica. The institution of Dr. Kasner has received research support from Bayer.